Zylox-Tonbridge Medical Technology Co., Ltd.
HKEX:2190.HK
11.02 (HKD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 1,086.579 | 1,205.302 | 1,418.359 | 59.556 | 46.13 |
| Short Term Investments
| 424.29 | 655.369 | 1,510.515 | 257.7 | 52 |
| Cash and Short Term Investments
| 1,510.869 | 1,860.671 | 2,928.874 | 317.256 | 98.13 |
| Net Receivables
| 1.182 | 1.014 | 0.446 | 0.129 | 1.013 |
| Inventory
| 166.542 | 119.244 | 57.272 | 28.993 | 9.955 |
| Other Current Assets
| 90.199 | 148.092 | 24.495 | 170.77 | 62.194 |
| Total Current Assets
| 1,717.181 | 2,062.599 | 3,024.208 | 370.142 | 125.284 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 547.392 | 311.017 | 193.347 | 108.521 | 56.775 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 43.791 | 45.715 | 29.717 | 21.209 | 24.167 |
| Goodwill and Intangible Assets
| 43.791 | 45.715 | 29.717 | 21.209 | 24.167 |
| Long Term Investments
| 1,066.196 | 177.067 | 0 | 0 | 0 |
| Tax Assets
| -3.137 | -177.067 | 0 | 0 | 0 |
| Other Non-Current Assets
| 4.278 | 834.365 | 1.014 | 4.099 | 0.834 |
| Total Non-Current Assets
| 1,658.52 | 1,191.097 | 224.078 | 133.829 | 81.776 |
| Total Assets
| 3,375.701 | 3,253.696 | 3,248.286 | 503.971 | 207.06 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 42.443 | 10.735 | 14.114 | 4.604 | 2.117 |
| Short Term Debt
| 54.018 | 6.543 | 2.896 | 6.575 | 15.351 |
| Tax Payables
| 6.312 | 8.933 | 4.468 | 0.665 | 0.234 |
| Deferred Revenue
| 218.733 | 0 | 75.613 | 39.188 | 0 |
| Other Current Liabilities
| -46.166 | 115.138 | -14.102 | -4.005 | 13.568 |
| Total Current Liabilities
| 317.783 | 152.084 | 97.103 | 51.631 | 33.387 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 1.859 | 7.459 | 6.509 | 27.646 | 7.998 |
| Deferred Revenue Non-Current
| 8.674 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| -8.674 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 8.674 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 10.533 | 7.459 | 6.509 | 27.646 | 7.998 |
| Total Liabilities
| 328.316 | 159.543 | 103.612 | 79.277 | 41.385 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 332.401 | 332.401 | 332.401 | 225.062 | 182.643 |
| Retained Earnings
| -481.907 | -403.173 | -289.618 | -361.515 | -261.047 |
| Accumulated Other Comprehensive Income/Loss
| 1,014.452 | 928.685 | 841.007 | 561.147 | 244.079 |
| Other Total Stockholders Equity
| 2,182.439 | 2,236.24 | 2,260.884 | 0 | 0 |
| Total Shareholders Equity
| 3,047.385 | 3,094.153 | 3,144.674 | 424.694 | 165.675 |
| Total Equity
| 3,047.385 | 3,094.153 | 3,144.674 | 424.694 | 165.675 |
| Total Liabilities & Shareholders Equity
| 3,375.701 | 3,253.696 | 3,248.286 | 503.971 | 207.06 |